Seven Eight Capital, LP Bristol Myers Squibb CO Transaction History

Seven Eight Capital, LP

$1.05 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$40.25 - $52.99 $380,362 - $500,755	9,450 New	9,450 $392,000
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $3.89 Million - $4.64 Million	80,225 Added 148.0%	134,432 $6.9 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $1.69 Million - $1.89 Million	29,263 Added 117.31%	54,207 $3.15 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $976,164 - $1.08 Million	15,322 Added 159.24%	24,944 $1.6 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $632,261 - $717,127	9,622 New	9,622 $666,000
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $2,188 - $1.29 Million	16,833 New	16,833 $1.2 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $9.51 Million - $11.1 Million	-177,285 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $8.69 Million - $10.2 Million	146,802 Added 481.59%	177,285 $10.5 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $172,295 - $187,629	2,783 Added 10.05%	30,483 $2.02 Million
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $115,480 - $130,860	-2,000 Reduced 6.73%	27,700 $1.72 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $1.71 Million - $1.89 Million	29,700 New	29,700 $1.78 Million
Q2 2020 Aug 06, 2020	SELL	$54.82 - $64.09 $1.2 Million - $1.4 Million	-21,800 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $839,608 - $1.22 Million	-18,095 Reduced 45.36%	21,800 $1.22 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $1.96 Million - $2.56 Million	39,895 New	39,895 $2.54 Million
Q2 2019 Aug 12, 2019	SELL	$44.62 - $49.34 $15.9 Million - $17.5 Million	-355,442 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $16 Million - $19.1 Million	355,442 New	355,442 $17 Million
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $6.24 Million - $7.18 Million	-104,059 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $2.77 Million - $3.02 Million	46,200 Added 79.85%	104,059 $6.38 Million
Q3 2017 Oct 16, 2017	SELL	$55.23 - $63.74 $629,622 - $726,636	-11,400 Reduced 16.46%	57,859 $3.69 Million
Q2 2017 Aug 10, 2017	BUY	N/A	69,259	69,259 $3.86 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.24 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.41 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.54 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.55 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Account